20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Cardiometabolic Syndrome in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barden, AE; Beilin, LJ; Mori, TA; Puddey, IB | 1 |
| Bradford, C; Falck, JR; Gotlinger, KH; Gupte, SA; Hunter, I; Hutcheson, B; Hutcheson, R; Joseph, G; Joshi, SR; Maniyar, R; Proctor, S; Rocic, P; Schwartzman, ML; Soler, A; Yang, J; Zhang, FF | 1 |
| Abraham, NG; Gotlinger, K; Jiang, H; Maher, E; O'Hanlon, K; Peterson, SJ; Shapiro, JI; Singh, SP; Sodhi, K; Vanella, L | 1 |
| Bradford, C; Falck, JR; Gotlinger, KH; Hunter, I; Hutcheson, B; Hutcheson, R; Jiang, H; Joseph, G; Proctor, S; Rocic, P; Schwartzman, ML; Soler, A | 1 |
| Barden, AE; Beilin, LJ; Croft, KD; Falck, JR; Mori, TA; Puddey, IB; Tsai, IJ | 1 |
2 review(s) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Alcohol and Hypertension-New Insights and Lingering Controversies.
Topics: Alcohol Drinking; Alcohol-Related Disorders; Blood Pressure; Cardiovascular Diseases; Cardiovascular System; Diabetes Mellitus, Type 2; Ethanol; Female; Humans; Hydroxyeicosatetraenoic Acids; Hypertension; Male; Mendelian Randomization Analysis; Metabolic Syndrome; Oxidative Stress; Risk Factors; Sex Factors | 2019 |
Oxidized HDL is a potent inducer of adipogenesis and causes activation of the Ang-II and 20-HETE systems in human obese females.
Topics: Adipocytes; Adipogenesis; Adiponectin; Adult; Angiotensin II; Blood Pressure; Body Mass Index; Case-Control Studies; F2-Isoprostanes; Female; Gene Expression Regulation; Heme Oxygenase-1; Humans; Hydroxyeicosatetraenoic Acids; Lipoproteins, LDL; Metabolic Syndrome; Middle Aged; Obesity; Primary Cell Culture; Tumor Necrosis Factor-alpha | 2016 |
1 trial(s) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Cardiometabolic Syndrome
| Article | Year |
|---|---|
20-HETE and F2-isoprostanes in the metabolic syndrome: the effect of weight reduction.
Topics: Adult; Aged; Biomarkers; Blood Pressure Monitoring, Ambulatory; Cardiovascular Diseases; F2-Isoprostanes; Female; Humans; Hydroxyeicosatetraenoic Acids; Hypertension; Male; Metabolic Syndrome; Middle Aged; Obesity; Oxidative Stress; Risk Factors; Weight Loss | 2009 |
2 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Elevated 20-HETE in metabolic syndrome regulates arterial stiffness and systolic hypertension via MMP12 activation.
Topics: Animals; Blood Pressure; Collagen Type I; Collagen Type III; Compliance; Cytochrome P-450 CYP4A; Cytochrome P450 Family 4; Diastole; Elastin; Enzyme Activation; Hydroxyeicosatetraenoic Acids; Hypertension; Losartan; Male; Matrix Metalloproteinase 12; Metabolic Syndrome; Proteolysis; Rats, Sprague-Dawley; RNA, Small Interfering; Vascular Stiffness | 2018 |
Elevated 20-HETE impairs coronary collateral growth in metabolic syndrome via endothelial dysfunction.
Topics: Animals; Antibodies, Blocking; Arterioles; Capillaries; Cell Adhesion Molecules; Collateral Circulation; Coronary Vessels; Endothelium, Vascular; Hydroxyeicosatetraenoic Acids; Male; Metabolic Syndrome; Myocardial Ischemia; Neutrophils; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley | 2017 |